Merck KGaA, IAVI and Serum Institute link up to develop COVID-19 mAbs
Agreement will see partners develop SARS-CoV-2 neutralising monoclonal antibodies
Read More
Tag: IAVI
MSD unveils bid to tackle coronavirus pandemic
The group will work on two experimental vaccines and an antiviral
Read More
- NICE backs daratumumab quadruplet for newly diagnosed transplant‑ineligible myeloma
- Anocca doses first patients with precision TCR‑T therapy
- Connecta launches phase 2a trial of neuroplasticity modulator
- Aquipta recommended by NICE for acute migraine treatment
- Talvey accepted for use in Scotland for relapsed and refractory multiple myeloma
